Total
0
Shares
Skin Elements (ASX:SKN) - Executive Chairman, Peter Malone
Executive Chairman, Peter Malone
Source: Business News
Market Herald logo

Subscribe

Be the first with the news that moves the market
  • Natural skincare company Skin Elements (SKN) has finalised the formulation for its Invisi Shield Natural hand sanitiser
  • Independent laboratory testing of Invisi Shield against a COVID-19 surrogate is currently underway in the United Kingdom
  • This test will determine Invisi Shield’s efficacy against the feline coronavirus, which is a surrogate of the coronavirus found in humans
  • Skin Elements has also announced that the first production run of Invisi Shield Natural is currently underway at its facility in Perth
  • Skin Elements has ended the day 4.17 per cent in the red with shares trading for 6.9 cents each

Natural skincare company Skin Elements (SKN) has finalised the formulation for its Invisi Shield Natural hand sanitiser.

The company today announced that its hand sanitiser is created using only natural plant-based extracts and no alcohol. It claims that the sanitiser is designed to deliver protection against 99.9 per cent of germs.

On April 2, Skin Elements and Holista CollTech entered a binding term sheet agreement to launch an all-natural hand sanitiser.

This agreement saw Skin Elements’ skin-sensitive, anti-microbial formula be combined with Holista’s Path-Away active ingredient.

Holista’s Path-Away is an active plant-based ingredient that is used in its NatShield alcohol-free hand sanitiser. It works by crippling a virus’ cell walls, causing bacteria to group together and destroy themselves within seconds.

It recently proved to be 99.99 per cent effective against feline coronavirus.

Both companies claim this sanitiser is softer on hands after repeated uses.

Independent laboratory testing of Invisi Shield against a COVID-19 surrogate is currently underway at a leading independent microbiology laboratory in the United Kingdom.

This testing is aiming to determine Invisi Shield’s efficacy against the feline coronavirus, which is a surrogate of the coronavirus found in humans.

The testing program is expected to be finished shortly and, once the results have been analysed and interpreted, assessments for any regulatory approvals will be undertaken.

The findings will also be released to the public.

Skin Elements has also announced that the first production run of Invisi Shield Natural is currently underway at its facility in Perth.

The company’s Invisi Shield Natural sanitiser is currently available for sale on its website.

Skin Elements’ range of hand sanitisers are relatively new to the market, only launched in mid-March.

For the past two years, the company has been researching, developing and testing its own hand sanitiser range.

This includes its Extended Life Hand Sanitiser, the Natural Hand Sanitiser, and the Natural Alcohol-Free Hand Sanitiser.

Skin Elements has ended the day 4.17 per cent in the red with shares trading for 6.9 cents each in a $22.87 million market cap.

SKN by the numbers
More From The Market Herald

" Rhinomed (ASX:RNO) receives ethics approval for Rhinoswab trial

Wearable nasal and respiratory company Rhinomed (RNO) has received ethics approval to undertake a clinical trial of Rhinoswab at St Vincents Hospital in
Anteris Technologies (ASX:AVR) - CEO, Wayne Paterson

" Anteris Technologies (ASX:AVR) eyes $5m for DurAVR

Anteris Technologies (AVR) has placed 625,000 new ordinary shares to Melbourne-based global investor L1 Capital to raise $5 million.
Atomo Diagnostics (ASX:AT1) - Managing Director, John Kelly

" Atomo (ASX:AT1) approved to supply and advertise HIV Self-Test

Atomo Diagnostics (AT1) can now supply its HIV self-test to a greater variety of organisations and begin advertising thanks to recent changes made
Starpharma (ASX:SPL) - CEO, Dr Jackie Fairley

" Starpharma (ASX:SPL) signs VIRALEZE supply deal for Vietnam

Starpharma (SPL) has penned an initial deal to distribute and supply its VIRALEZE antiviral nasal spray in Vietnam.